Voltage-gated ion channels, new targets in anti-cancer research.

Abstract : Cancer is one of the leading causes of mortality in the world. This is a complex disease involving many steps with proper signalling pathways. Early detection and treatment of cancers have increased survival and improved clinical outcome. However, novel strategies based on new interesting targets are needed to improve the conventional treatments. A few years ago, it appeared that some particular transmembrane proteins, ion channels, may be involved in the development of the disease. Since then, their role in cancer cell properties such as proliferation, migration and invasion begins to be unravelled. These proteins have been widely studied in non cancerous cells as well as in pathologies involving excitable cells and thus, their pharmacology are quite well known. In this review, we summarize the present knowledge about the role of different ion channels in some aspects of the development of tumours, mainly proliferation, migration and invasion. A particular emphasis is done on promising new patents.
Type de document :
Article dans une revue
Recent Patents Anticancer Drug Discov, 2007, 2 (3), pp.189-202
Liste complète des métadonnées

https://www.hal.inserm.fr/inserm-00248386
Contributeur : Jean-Yves Le Guennec <>
Soumis le : vendredi 8 février 2008 - 11:28:08
Dernière modification le : lundi 2 juillet 2018 - 16:20:15
Document(s) archivé(s) le : vendredi 25 novembre 2016 - 20:29:05

Fichiers

 Accès restreint
Fichier visible le : jamais

Connectez-vous pour demander l'accès au fichier

  •  Figures_Legends.pdf    Visible le : jamais 
  •  LeGuennec_Ion_Channel.pdf    Visible le : jamais 

Identifiants

  • HAL Id : inserm-00248386, version 1
  • PUBMED : 18221062

Collections

Citation

Jean-Yves Le Guennec, Halima Ouadid-Ahidouch, Olivier Soriani, Pierre Besson, Ahmed Ahidouch, et al.. Voltage-gated ion channels, new targets in anti-cancer research.. Recent Patents Anticancer Drug Discov, 2007, 2 (3), pp.189-202. 〈inserm-00248386〉

Partager

Métriques

Consultations de la notice

103